MGNX Earnings

MGNX reported its earnings on 2025-08-12, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.59 by 0%. The stock experienced a 0% price change on the earnings day and a 3.4% change over the next five days, reflecting market reactions to the results.

Following MGNX's earnings announcement on 2025-08-12, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 3.4% change. Historically, MGNX's stock price tends to shift by an average of 3.55% in the 10 days leading up to earnings and -10.93% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate MGNX's annual revenue to reach 27.81M, while the EPS is projected at -0.29. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between MGNX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, MGNX's stock price typically moves by 3.55% in the 10 days before its earnings and -10.93% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.29 and revenue of 27.81M.

The earnings call presents mixed signals: strong revenue growth from milestone achievements but significant net losses and increased expenses. The absence of a shareholder return plan and management's unclear responses in the Q&A add uncertainty. However, the optimistic guidance on future clinical trials and potential market expansion balance the negatives. Given these factors, the stock is expected to remain stable in the short term, resulting in a neutral sentiment.